|
|
|
Insider
Information: |
Parshall B Lynne |
Relationship: |
Director |
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
5,619,493 |
|
Indirect Shares
|
7,049,500 |
|
|
Direct
Value |
$16,734,476 |
|
|
Indirect Value
|
$16,143,355 |
|
|
Total
Shares |
12,668,993 |
|
|
Total
Value |
$32,877,831 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
0.0%
|
-84.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-12-28 |
82,588 |
2016-12-15 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2024-05-15 |
20,600 |
2020-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,136 |
68,702 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
66,575 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
889 |
67,464 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-23 |
4 |
AS |
$50.12 |
$160,384 |
D/D |
(3,200) |
67,464 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-23 |
4 |
OE |
$39.87 |
$127,584 |
D/D |
3,200 |
70,664 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-24 |
4 |
AS |
$50.82 |
$36,082 |
D/D |
(710) |
67,464 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-24 |
4 |
OE |
$39.87 |
$28,308 |
D/D |
710 |
68,174 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-25 |
4 |
OE |
$39.87 |
$143,133 |
D/D |
3,590 |
71,054 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-11-25 |
4 |
AS |
$50.05 |
$179,680 |
D/D |
(3,590) |
67,464 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2020-12-23 |
4 |
AS |
$60.00 |
$600,000 |
D/D |
(10,000) |
57,464 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2021-01-15 |
4 |
D |
$61.28 |
$167,968 |
D/D |
(2,741) |
65,378 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,655 |
68,119 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
73,378 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,754 |
79,132 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2022-01-18 |
4 |
D |
$30.12 |
$49,758 |
D/D |
(1,652) |
77,480 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,998 |
85,478 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,110 |
92,588 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-26 |
4 |
S |
$51.46 |
$1,292,390 |
D/D |
(25,113) |
82,588 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-26 |
4 |
OE |
$47.34 |
$1,188,849 |
D/D |
25,113 |
107,701 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-27 |
4 |
S |
$50.23 |
$2,511,515 |
D/D |
(50,000) |
82,588 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-27 |
4 |
OE |
$47.34 |
$2,367,000 |
D/D |
50,000 |
132,588 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-28 |
4 |
S |
$50.19 |
$2,134,223 |
D/D |
(42,525) |
82,588 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Director |
|
2023-12-28 |
4 |
OE |
$47.34 |
$2,013,134 |
D/D |
42,525 |
125,113 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2012-10-10 |
4 |
B |
$4.00 |
$3,000,000 |
I/I |
750,000 |
7,049,500 |
2.25 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2012-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
6,299,500 |
6,299,500 |
0 |
- |
|
304 Records found
|
|
Page 10 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|